TETERBORO, N.J., Oct 7, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, announced that Kenneth W. Freeman,
Chairman and Chief Executive Officer and Surya N. Mohapatra, Ph.D., President
and Chief Operating Officer, are scheduled to speak at the UBS Warburg Global
Life Sciences Conference on Tuesday, October 8, 2002, at The Plaza Hotel, New
York, New York. The Quest Diagnostics presentation is scheduled to begin at
10:00 a.m. Eastern Time.
Audio of the presentation will be presented live during the conference and will
be available to investors on the UBS Warburg's site at:
http://www.ubswarburg.com. Access to this site is public, and requires no
password. The webcast will also be available on the Quest Diagnostics website
at: http://www.questdiagnostics.com. In addition, the archived webcast will be
available three hours after the actual presentation time and will be available
until November 10, 2002.
Quest Diagnostics Incorporated is the nation's leading provider of diagnostic
testing, information and services, providing insights that enable physicians,
hospitals, managed care organizations and other healthcare professionals to make
decisions to improve health. The company offers the broadest access to
diagnostic laboratory services through its national network of laboratories and
patient service centers. Quest Diagnostics is the leading provider of esoteric
testing, including gene-based medical testing, and empowers healthcare
organizations and clinicians with state-of-the-art connectivity solutions that
improve practice management. Additional company information can be found on the
Internet at: www.questdiagnostics.com.
The statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking statements
involve risks and uncertainties that could cause the outcome to be materially
different. Certain of these risks and uncertainties are listed in the Quest
Diagnostics Incorporated 2001 Form 10-K and subsequent filings.
SOURCE Quest Diagnostics Incorporated
CONTACT:
Investors, Laure Park, +1-201-393-5030, or Media, Gary Samuels,
+1-201-393-5700, both of Quest Diagnostics
URL: http://www.questdiagnostics.com
Copyright (C) 2002 PR Newswire. All rights reserved.